Feng Biosciences
PrivateLast Round
Series B
Mar 3, 2022
Total Funding Raised
$126.5M
Company Overview
Feng Biosciences operates in Healthcare & Life Sciences and is based in Waltham, Massachusetts. Its latest recorded funding round was a Series B round in March 2022.
Feng Biosciences is a biotechnology company that develops cancer therapies using a proprietary RNA-based biomarker platform and immunomodulatory monoclonal antibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Feng Biosciences Comparables
Compare Feng Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cofactor Genomics | 84% | |
| GeneCentric | 83% | |
| Novigenix AI | 79% |
For institutional investors. Book with your work email.
Feng Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 3, 2022 | ||||
| Series B | Jun 10, 2019 | ||||
| Seed | Jun 7, 2018 |
For institutional investors. Book with your work email.
Feng Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Partners | Series B |
| Nan Fung Life Sciences | Seed, Series B |
| Volcanics Venture | Seed |
| Panacea Venture Healthcare | Series B |
| Korea Investment Partners | Series B |
| Pivotal bioVenture Partners China | Seed, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 7, 2018
$17M round led by Pivotal bioVenture Partners China.
For institutional investors. Book with your work email.
Feng Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Feng Biosciences's valuation, stock price, and market status.
Is Feng Biosciences a public or private company?
Feng Biosciences is a private company.
What is the current stock price of Feng Biosciences?
Feng Biosciences is a private company, so its shares have no public market price. Caplight tracks Feng Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Feng Biosciences worth (valuation)?
Valuation information for Feng Biosciences is not publicly available.
Can I buy Feng Biosciences stock?
Feng Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Feng Biosciences's last funding round?
Feng Biosciences's most recent funding round was Series B on March 3, 2022.
Who are the main investors in Feng Biosciences?
Key investors in Feng Biosciences include Nan Fung Life Sciences, Pivotal bioVenture Partners China.
Will Feng Biosciences IPO soon?
No public IPO plans have been announced for Feng Biosciences.
How can I track Feng Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Feng Biosciences's shares on secondary markets.